Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Distil (DIS) by Steve Moore in ShareProphets
- Add Phoenix Group Holdings (PHNX) by Simon Watkins in The Motley Fool
- Buy Greencore Group (CDI) (GNC) by Deutsche Bank
- Hold Sage Group (SGE) by Deutsche Bank
- Underweight Pagegroup (PAGE) by Morgan Stanley
- Underweight Hays (HAS) by Morgan Stanley
- Neutral Man Group (EMG) by Citi
- Neutral Abrdn (ABDN) by Citi
- Outperform Hunting (HTG) by RBC Capital
- Hold WH Smith (SMWH) by Berenberg
- Buy The Gym Group (GYM) by Berenberg
- Hold Whitbread (WTB) by Berenberg
- Buy Flutter Entertainment (DI) (FLTR) by Berenberg
- Buy Man Group (EMG) by Jefferies
- Overweight NATWEST GROUP (NWG) by JP Morgan
- Neutral Lloyds Banking Group (LLOY) by JP Morgan
- Overweight Barclays (BARC) by JP Morgan
- Hold Dunelm Group (DNLM) by Guy Taylor in The Times - Tempus
- Buy Acg Metals Limited Cls A Npv (DI) (ACG) by Berenberg
- Buy Acg Metals Limited Cls A Npv (DI) (ACG) by Canaccord Genuity
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,249 open tips for AstraZeneca (AZN)
| Latest Bid : 13,494.00p | Latest Ask : 13,498.00p |
| High Today : 13,786.00p | Low Today : 13,474.52p |
| This Years High : 14,346.00p | This Years Low : 9,667.00p |
| Volume : 467,096 | MKT Cap : £209219M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | -3.79% |
| Buy | UBS | Premium Only | 2026-01-16 08:57:00 16/01/2026 | -4.01% |
| Sell | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | 3.72% |
| Overweight | Barclays | Premium Only | 2026-01-07 06:18:00 07/01/2026 | -3.96% |
| Overweight | JP Morgan | Premium Only | 2026-01-06 18:00:00 06/01/2026 | -3.96% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13,494.00p | Latest Ask : 13,498.00p |
| High Today : 13,786.00p | Low Today : 13,474.52p |
| This Years High : 14,346.00p | This Years Low : 9,667.00p |
| Volume : 467,096 | MKT Cap : £209219M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Shore Capital | Premium Only | 2026-01-16 14:46:00 16/01/2026 | -3.79% |
| Buy | UBS | Premium Only | 2026-01-16 08:57:00 16/01/2026 | -4.01% |
| Sell | Deutsche Bank | Premium Only | 2026-01-16 07:11:00 16/01/2026 | 3.72% |
| Overweight | Barclays | Premium Only | 2026-01-07 06:18:00 07/01/2026 | -3.96% |
| Overweight | JP Morgan | Premium Only | 2026-01-06 18:00:00 06/01/2026 | -3.96% |